Literature DB >> 18462581

New horizons for the infectious diseases specialist: how gut microflora promote health and disease.

Shervin Rabizadeh1, Cynthia Sears.   

Abstract

The human intestine provides an expansive interface for interactions with the microflora. Increasing data support the hypothesis that host-microflora relationships are markedly dynamic, contributing to host health and disease pathogenesis. Despite outnumbering human cells 10-fold, the microflora most often assist the host through symbiotic relationships. The microflora are involved in maximizing host utilization of nutrients, induction of host immune responses, and promotion of intestinal cell and mucosal development. However, evolving data suggest that disturbances in this symbiotic relationship can lead the microflora to be pathogenic in diverse conditions such as inflammatory bowel disease, irritable bowel disease, obesity, graft-versus-host disease, HIV immunopathogenesis, and possibly cancer. Defining those microflora attributes that result in health and those that trigger disease is key to harnessing the microflora to promote human health.

Entities:  

Year:  2008        PMID: 18462581      PMCID: PMC3074359          DOI: 10.1007/s11908-008-0017-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  49 in total

1.  Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

Authors:  A S Neish; A T Gewirtz; H Zeng; A N Young; M E Hobert; V Karmali; A S Rao; J L Madara
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

2.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

Review 3.  The genetics of inflammatory bowel disease.

Authors:  Judy H Cho; Casey T Weaver
Journal:  Gastroenterology       Date:  2007-10       Impact factor: 22.682

4.  Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system.

Authors:  Wendy S Garrett; Graham M Lord; Shivesh Punit; Geanncarlo Lugo-Villarino; Sarkis K Mazmanian; Susumu Ito; Jonathan N Glickman; Laurie H Glimcher
Journal:  Cell       Date:  2007-10-05       Impact factor: 41.582

5.  Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells.

Authors:  Yun Tao; Kenneth A Drabik; Tonya S Waypa; Mark W Musch; John C Alverdy; Olaf Schneewind; Eugene B Chang; Elaine O Petrof
Journal:  Am J Physiol Cell Physiol       Date:  2005-11-23       Impact factor: 4.249

6.  Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery.

Authors:  John K Marshall; Marroon Thabane; Amit X Garg; William F Clark; Marina Salvadori; Stephen M Collins
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

7.  Glycan foraging in vivo by an intestine-adapted bacterial symbiont.

Authors:  Justin L Sonnenburg; Jian Xu; Douglas D Leip; Chien-Huan Chen; Benjamin P Westover; Jeremy Weatherford; Jeremy D Buhler; Jeffrey I Gordon
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

8.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

Review 9.  Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology.

Authors:  P G Falk; L V Hooper; T Midtvedt; J I Gordon
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

10.  Development of the human infant intestinal microbiota.

Authors:  Chana Palmer; Elisabeth M Bik; Daniel B DiGiulio; David A Relman; Patrick O Brown
Journal:  PLoS Biol       Date:  2007-06-26       Impact factor: 8.029

View more
  11 in total

1.  Structure, function and latency regulation of a bacterial enterotoxin potentially derived from a mammalian adamalysin/ADAM xenolog.

Authors:  Theodoros Goulas; Joan L Arolas; F Xavier Gomis-Rüth
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-13       Impact factor: 11.205

2.  Combined probiotic bacteria promotes intestinal epithelial barrier function in interleukin-10-gene-deficient mice.

Authors:  Chen-Zhang Shi; Hong-Qi Chen; Yong Liang; Yang Xia; Yong-Zhi Yang; Jun Yang; Jun-Dong Zhang; Shu-Hai Wang; Jing Liu; Huan-Long Qin
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

3.  The structure of Acinetobacter-secreted protease CpaA complexed with its chaperone CpaB reveals a novel mode of a T2SS chaperone-substrate interaction.

Authors:  Darya V Urusova; Rachel L Kinsella; Nichole D Salinas; M Florencia Haurat; Mario F Feldman; Niraj H Tolia
Journal:  J Biol Chem       Date:  2019-07-18       Impact factor: 5.157

4.  Helicobacter pylori vs coronary heart disease - searching for connections.

Authors:  Magdalena Chmiela; Adrian Gajewski; Karolina Rudnicka
Journal:  World J Cardiol       Date:  2015-04-26

Review 5.  The intestinal microbiome and health.

Authors:  Susan Tuddenham; Cynthia L Sears
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

6.  Finding Potential Therapeutic Targets against Shigella flexneri through Proteome Exploration.

Authors:  Mohammad Uzzal Hossain; Md Arif Khan; Abu Hashem; Md Monirul Islam; Mohammad Neaz Morshed; Chaman Ara Keya; Md Salimullah
Journal:  Front Microbiol       Date:  2016-11-22       Impact factor: 5.640

7.  Drug Discovery and Repurposing Inhibits a Major Gut Pathogen-Derived Oncogenic Toxin.

Authors:  Paul Metz; Martijn J H Tjan; Shaoguang Wu; Mehrosh Pervaiz; Susanne Hermans; Aishwarya Shettigar; Cynthia L Sears; Tina Ritschel; Bas E Dutilh; Annemarie Boleij
Journal:  Front Cell Infect Microbiol       Date:  2019-10-25       Impact factor: 5.293

8.  Identification and characterization of potential therapeutic candidates in emerging human pathogen Mycobacterium abscessus: a novel hierarchical in silico approach.

Authors:  Buvaneswari Shanmugham; Archana Pan
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

9.  Dietary patterns and colorectal cancer recurrence and survival: a cohort study.

Authors:  Yun Zhu; Hao Wu; Peizhong Peter Wang; Sevtap Savas; Jennifer Woodrow; Tyler Wish; Rong Jin; Roger Green; Michael Woods; Barbara Roebothan; Sharon Buehler; Elizabeth Dicks; John R McLaughlin; Peter T Campbell; Patrick S Parfrey
Journal:  BMJ Open       Date:  2013-02-07       Impact factor: 2.692

Review 10.  Epidemiology of infections in cancer patients.

Authors:  Teresa R Zembower
Journal:  Cancer Treat Res       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.